Skip to content

Folic Acid Supplementation in Postpolypectomy Patients in a Randomized Controlled Trial Increases Tissue Folate Concentrations and Reduces Aberrant DNA Biomarkers in Colonic Tissues Adjacent to the Former Polyp Site.

The Journal of nutrition
Q1
Apr 2016
Citations: 26
Influential: 1
Interventional (Human) Studies
93

What this study found

Folic acid supplementation improved colonocyte folate status and favorable folate-related DNA biomarkers in tissue adjacent to the former polyp site. In the active arm, adjacent-site colonocyte folate increased by 2.5 pg/10^5 cells versus 0.4 pg/10^5 cells with placebo (P = 0.045), global DNA hypomethylation fell from 1.7 ± 0.1 to 1.0 ± 0.1 (P < 0.001), and uracil misincorporation decreased by 0.5 ± 0.1 over time (P = 0.05), with a greater adjacent-site change than placebo (P = 0.05). Distal-site global DNA hypomethylation also improved with folic acid (P = 0.017), and no adverse events were…

Study & population
Randomized controlled trial conducted at a single Dublin hospital in adults with adenomatous colorectal polyps after polypectomy.
Intervention
Folic acid 600 mg/d was given for 6 months in the active treatment arm; the route and exact dosing frequency were not stated.
Key limitation
The trial was small, with only 12 participants in the folic acid arm and 8 in placebo, limiting precision and generalizability.
View sourceOpen PDF

Original abstract

BACKGROUND Low folate status is associated with an increased risk of colorectal carcinogenesis. Optimal folate status may be genoprotective by preventing uracil misincorporation into DNA and DNA hypomethylation. Adenomatous polyps have low folate status compared with normal colonic mucosa, and they are surrounded by histologically normal mucosa that also is of low folate status. OBJECTIVE In a randomized controlled trial conducted at a single Dublin hospital between April 2002 and March 2004, we assessed the effect of folic acid supplementation on tissue folate, uracil misincorporation into DNA, and global DNA hypomethylation in colonocytes isolated from sites of adenomatous polyps and from histologically normal tissue adjacent and 10-15 cm distal to them. METHODS Twenty patients with adenomatous polyps on initial colonoscopy and polypectomy were randomly assigned to receive either 600 μg folic acid/d [n = 12, 38% men, mean age 64.3 y, and body mass index (BMI, in kg/m(2)) 26.6] or placebo (n = 8, 50% men, mean age 68.4 y, and BMI 27.2) for 6 mo, and then repeat the colonoscopy. Blood and colonocyte tissue folate concentrations were measured with the use of a microbiological assay. Uracil misincorporation and global DNA hypomethylation were measured in colonocytes with the use of modified comet assays. RESULTS Over time, folic acid supplementation, compared with placebo, increased tissue folate (mean ± SEM) from 15.6 ± 2.62 pg/10(5) cells to 18.1 ± 2.12 pg/10(5) cells (P < 0.001) and decreased the global DNA hypomethylation ratio from 1.7 ± 0.1 to 1.0 ± 0.1 (P < 0.001). The uracil misincorporation ratio decreased by 0.5 ± 0.1 for the site adjacent to the polyp over time (P = 0.05). CONCLUSION A response to folic acid supplementation, which increased colonocyte folate and improved folate-related DNA biomarkers of cancer risk, was seen in the participants studied. Exploratory analysis points toward the area formerly adjacent to polyps as possibly driving the response. That these areas persist after polypectomy in the absence of folate supplementation is consistent with a potentially carcinogenic field's causing the appearance of the polyp.